Skip to main content
Top
Published in: Metabolic Brain Disease 1/2018

01-02-2018 | Short Communication

Aversive and non-aversive memory impairment in the mucopolysaccharidosis II mouse model

Authors: Amanda Stapenhorst Azambuja, Lilian Correa, Bernardo Pappi Gabiatti, Giselle Renata Martins, Álvaro de Oliveira Franco, Maria Flávia Marques Ribeiro, Guilherme Baldo

Published in: Metabolic Brain Disease | Issue 1/2018

Login to get access

Abstract

Hunter syndrome (MPS II, OMIM 309900) is a lysosomal storage disorder due to deficient iduronate sulphatase activity. Patients present multiple cognitive alterations, and the aim of this work was to verify if MPS II mice also present some progressive cognitive alterations. For that, MPS II mice from 2 to 6 months of age were submitted to repeated open field and inhibitory avoidance tests to evaluate memory parameters. MPS II mice presented impaired memory at 6 months evaluated by open field test. They also performed poorly in the inhibitory avoidance test from 4 months. We conclude that MPS II mice develop cognitive alterations as the disease progresses. These tests can be used in the future to study the efficacy of therapeutic approaches in the central nervous system.
Literature
go back to reference Baldo G, Lorenzini DM, Santos DS, Mayer FQ, Vitry S, Bigou S, Heard JM, Matte U, Giugliani R (2015) Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice. Mol Genet Metab 114(2):138–145CrossRefPubMed Baldo G, Lorenzini DM, Santos DS, Mayer FQ, Vitry S, Bigou S, Heard JM, Matte U, Giugliani R (2015) Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice. Mol Genet Metab 114(2):138–145CrossRefPubMed
go back to reference Brusius-Facchin AC, Schwartz IV, Zimmer C, Ribeiro MG, Acosta AX, Horovitz D, Monlleó IL, Fontes MI, Fett-Conte A, Sobrinho RP, Duarte AR, Boy R, Mabe P, Ascurra M, de Michelena M, Tylee KL, Besley GT, Garreton MC, Giugliani R, Leistner-Segal S (2014) Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients. Mol Genet Metab 111(2):133–138CrossRefPubMed Brusius-Facchin AC, Schwartz IV, Zimmer C, Ribeiro MG, Acosta AX, Horovitz D, Monlleó IL, Fontes MI, Fett-Conte A, Sobrinho RP, Duarte AR, Boy R, Mabe P, Ascurra M, de Michelena M, Tylee KL, Besley GT, Garreton MC, Giugliani R, Leistner-Segal S (2014) Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients. Mol Genet Metab 111(2):133–138CrossRefPubMed
go back to reference Garcia AR, Pan J, Lamsa JC, Muenzer J (2007) The characterization of a murine model of mucopolysaccharidosis II (hunter syndrome). J Inherit Metab Dis 30(6):924–934CrossRefPubMed Garcia AR, Pan J, Lamsa JC, Muenzer J (2007) The characterization of a murine model of mucopolysaccharidosis II (hunter syndrome). J Inherit Metab Dis 30(6):924–934CrossRefPubMed
go back to reference Gleitz HFE et al (2017) Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis type II. PLoS One 12(2):e0172435CrossRefPubMedPubMedCentral Gleitz HFE et al (2017) Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis type II. PLoS One 12(2):e0172435CrossRefPubMedPubMedCentral
go back to reference Hinderer C, Katz N, Louboutin JP, Bell P, Yu H, Nayal M, Kozarsky K, O'Brien WT, Goode T, Wilson JM (2016) Delivery of an adeno-associated virus vector into cerebrospinal fluid attenuates central nervous system disease in Mucopolysaccharidosis type II mice. Hum Gene Ther 27(11):906–915CrossRefPubMed Hinderer C, Katz N, Louboutin JP, Bell P, Yu H, Nayal M, Kozarsky K, O'Brien WT, Goode T, Wilson JM (2016) Delivery of an adeno-associated virus vector into cerebrospinal fluid attenuates central nervous system disease in Mucopolysaccharidosis type II mice. Hum Gene Ther 27(11):906–915CrossRefPubMed
go back to reference Pan D, Sciascia A 2nd, Vorhees CV, Williams MT (2008) Progression of multiple behavioral deficits with various ages of onset in a murine model of hurler syndrome. Brain Res 1188:241–253CrossRefPubMed Pan D, Sciascia A 2nd, Vorhees CV, Williams MT (2008) Progression of multiple behavioral deficits with various ages of onset in a murine model of hurler syndrome. Brain Res 1188:241–253CrossRefPubMed
go back to reference Yund B, Rudser K, Ahmed A, Kovac V, Nestrasil I, Raiman J, Mamak E, Harmatz P, Steiner R, Lau H, Vekaria P, Wozniak JR, Lim KO, Delaney K, Whitley C, Shapiro EG (2015) Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II. Mol Genet Metab 114(2):170–177CrossRefPubMed Yund B, Rudser K, Ahmed A, Kovac V, Nestrasil I, Raiman J, Mamak E, Harmatz P, Steiner R, Lau H, Vekaria P, Wozniak JR, Lim KO, Delaney K, Whitley C, Shapiro EG (2015) Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II. Mol Genet Metab 114(2):170–177CrossRefPubMed
Metadata
Title
Aversive and non-aversive memory impairment in the mucopolysaccharidosis II mouse model
Authors
Amanda Stapenhorst Azambuja
Lilian Correa
Bernardo Pappi Gabiatti
Giselle Renata Martins
Álvaro de Oliveira Franco
Maria Flávia Marques Ribeiro
Guilherme Baldo
Publication date
01-02-2018
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 1/2018
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-017-0110-5

Other articles of this Issue 1/2018

Metabolic Brain Disease 1/2018 Go to the issue